Optical-guided sentinel node biopsy for vulvar cancer staging
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary vulvar cancer or a single recurrence in the vulva
- Your tumor is smaller than 4 centimeters (about 1.6 inches)
- You have not had radiation to the vulva or groin area before
- You have not had a sentinel node biopsy or groin lymph node removal on the affected side before
- You are not allergic to ICG (a green dye used for imaging) or iodine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This study compares two methods for finding the first lymph node (sentinel node) that may contain cancer in people with vulvar cancer. It uses a dye called indocyanine green alone or with a radioactive tracer (technetium) to see which approach works better for staging the disease.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This study tests a new device that uses augmented reality and a special dye to help surgeons find the sentinel lymph node (the first node that cancer might spread to) during breast cancer surgery. It may help make the node removal more precise and reduce unnecessary removal.
Hear when a new Vulvar Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.